KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment

J Infect Dis. 2019 Jun 5;220(1):174-176. doi: 10.1093/infdis/jiz056.

Authors

Kristian Tonby¹, Rasmus Mortensen², Morten Ruhwald², Anne Ma Dyrhol-Riise^{3

4

5}, Synne Jenum¹

Affiliations

¹ Department of Infectious Diseases, Oslo University Hospital, Norway.
² Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.
³ Department of Infectious Diseases, Oslo University Hospital.
⁴ Institute of Clinical Medicine, Department of Infectious Diseases, University of Oslo.
⁵ Department of Clinical Science, University of Bergen, Norway.

PMID: 30888024
DOI: 10.1093/infdis/jiz056

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

CD4-Positive T-Lymphocytes
Healthy Volunteers
Humans
Lectins, C-Type
Mycobacterium tuberculosis*
Programmed Cell Death 1 Receptor
Receptors, Immunologic
Trans-Activators
Tuberculosis*

Substances

KLRG1 protein, human
Lectins, C-Type
Programmed Cell Death 1 Receptor
Receptors, Immunologic
Trans-Activators

Associated data

ClinicalTrials.gov/NCT02503839